Ward Shane
Insider CIK 1638380 · BLCM Sr. VP and General Counsel · VSAR SVP, Legal and Compliance · CDTX COO & CLO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 135,540 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 50,000 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 12,499 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 6,207 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 12,500 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer | 2026-01-07 | 2026-01-07 | 25,083 | $221.50 | $5.56M | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | M Exercise deriv | 2025-12-10 | 2025-12-12 | 3,500 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | M Exercise deriv | 2025-12-10 | 2025-12-12 | 6,459 | — | $0 | 6,207 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | M Exercise | 2025-12-10 | 2025-12-12 | 6,459 | $20.20 | $130.5K | 34,592 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | M Exercise | 2025-12-10 | 2025-12-12 | 3,500 | $16.65 | $58.3K | 28,133 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | F Tax w/h | 2025-12-10 | 2025-12-12 | 15,041 | $219.60 | $3.30M | 24,633 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | S Sale | 2025-12-10 | 2025-12-12 | 9,959 | $220.08 | $2.19M | 25,033 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2025-03-31 | 2025-04-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2025-03-31 | 2025-04-02 | 25,000 | — | $0 | 39,674 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | S Sale | 2025-03-11 | 2025-03-13 | 1,664 | $21.96 | $36.5K | 14,674 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2024-09-30 | 2024-10-02 | 135,540 | — | $0 | 135,540 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2024-03-15 | 2024-03-20 | 250,000 | — | $0 | 250,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2024-03-15 | 2024-03-20 | 120,000 | — | $0 | 318,770 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | S Sale | 2024-03-11 | 2024-03-12 | 20,473 | $0.67 | $13.7K | 198,770 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2023-03-27 | 2023-03-29 | 253,333 | — | $0 | 253,333 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2023-03-27 | 2023-03-29 | 126,667 | — | $0 | 211,243 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | S Sale | 2023-03-13 | 2023-03-13 | 4,329 | $1.53 | $6.6K | 84,576 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2022-03-31 | 2022-04-04 | 70,000 | — | $0 | 70,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | F Tax w/h | 2022-03-31 | 2022-04-04 | 23,122 | $0.83 | $19.2K | 80,905 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2022-03-31 | 2022-04-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2022-03-31 | 2022-04-04 | 69,027 | — | $0 | 104,027 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2021-08-25 | 2021-08-27 | 250,000 | — | $0 | 250,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | F Tax w/h | 2020-05-29 | 2020-06-02 | 107 | $7.63 | $816 | 1,879 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2020-04-08 | 2020-04-09 | 21,864 | — | $0 | 21,864 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2020-02-03 | 2020-02-04 | 410,000 | — | $0 | 410,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | P Buy | 2019-08-29 | 2019-08-30 | 8,000 | $1.23 | $9.8K | 18,294 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2019-06-11 | 2019-06-11 | 45,000 | — | $0 | 45,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | F Tax w/h | 2019-05-29 | 2019-05-30 | 1,065 | $2.09 | $2.2K | 8,935 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2019-02-01 | 2019-02-05 | 45,000 | — | $0 | 45,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2018-05-29 | 2018-05-29 | 120,000 | — | $0 | 120,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award | 2018-05-29 | 2018-05-29 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2018-02-08 | 2018-02-12 | 4,118 | $1.80 | $7.4K | 201,556 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2017-12-20 | 2017-12-22 | 93,100 | — | $0 | 205,674 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2017-11-28 | 2017-11-29 | 20,000 | — | $0 | 112,574 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-10-19 | 2017-10-23 | 776 | $2.55 | $2.0K | 92,574 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2017-10-06 | 2017-10-10 | 57,000 | — | $0 | 93,350 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-03-15 | 2017-03-15 | 776 | $19.02 | $14.8K | 36,350 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-03-14 | 2017-03-15 | 1,265 | $19.00 | $24.0K | 37,126 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-01-30 | 2017-01-31 | 1,474 | $13.85 | $20.4K | 38,391 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2017-01-27 | 2017-01-31 | 46,200 | — | $0 | 46,200 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2017-01-27 | 2017-01-31 | 20,600 | — | $0 | 39,865 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2016-10-11 | 2016-10-13 | 5,000 | — | $0 | 19,265 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2016-01-28 | 2016-02-01 | 42,000 | — | $0 | 42,000 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2016-01-28 | 2016-02-01 | 13,000 | — | $0 | 14,265 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2015-04-06 | 2015-04-08 | 50,000 | — | $0 | 50,000 | SEC↗ |